Angela O'Neill
Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress
Paragonix Technologies presented new clinical data at the American Transplant Congress (ATC) on the ...
First coronary patient enrolled in FDA IDE study of drug eluting balloon
MedAlliance has announced enrollment of the first patient in its study of Selution SLR 014” drug...
Black patients have higher rates of death after PCI
Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for m...
Ancora Heart receives IDE approval for study of AccuCinch
Ancora Heart has been given US Food and Drug Administration (FDA) approval of its investigationa...
American Heart Association appoints Mitchell Elkind as president
The American Heart Association (AHA) has named Mitchell SV Elkind as president of the organisati...
Use of Impella CP is feasible in patients with severe aortic stenosis during high-risk percutaneous coronary intervention
Using an Impella device is contraindicated in patients with severe aortic stenosis with a valve ...
NuVera announces successful first-in-human use of NuVision ICE catheter
NuVera Medical has announced the initiation of the company's first-in-human clinical trial to ev...
A higher volume of mitral valve repair procedures is associated with lower mortality rates
US national hospital- and surgeon-level inverse volume–outcome associations were observed for 30...
Morning exercise is the key to a good night’s sleep after heart bypass surgery
Patients who have trouble sleeping after heart bypass surgery should go for a morning walk, accord...
MedAlliance gains CE mark for coronary Selution SLR sirolimus drug eluting balloon
MedAlliance has been awarded CE mark for the Selution SLR 014 percutaneous transluminal coronary ang...
CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era
BioCardia has announced that it has resumed cases in the CardiAMP Heart Failure Trial. The first...
PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient
The feasibility, safety, and efficiency of transcatheter aortic valve implantation (TAVI) using ...
PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair is sustained at one year
One-year results from the TRILUMINATE study show that TriClip (Abbott) transcatheter therapy for...
PCR e-Course 2020: DynamX Bioadaptor shows “excellent” safety and efficacy at 12 months
Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting Coronary Bioadaptor s...
PCR e-Course 2020: DEFINITION II finds two-stent approach better than provisional in complex lesions
A systematic two-stent approach in complex coronary bifurcation lesions is associated with a sig...
PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure
Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO trial to the renal ...
PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findings from the study, d...
First evaluation of long-term outcomes after aortic valve-in-valve presented at PCR e-Course 2020
Long-term clinical outcomes, including mortality, following an aortic valve-in-valve procedure m...
PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via a transseptal approach
Use of the transseptal Evoque transmitral valve replacement (TMVR) system (Edwards Lifesciences)...
PCR e-Course 2020: Mitral valve-in-valve and valve-in-ring strategies often require repeat procedures
A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring (ViR) procedures has...
Miracor Medical’s PiCSO System receives CE mark
Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impuls...
Evolut gets CE mark in low-risk patients and new labelling for bicuspid use
Medtronic has been awarded CE mark for the use of the Evolut transcatheter aortic valve implanta...
Proximo Medical and Coala Life announce partnership for US markets
Proximo Medical has announced a partnership with digital health company Coala Life in select US ...
Abiomed initiates online education platform for PCI
Abiomed has launched a virtual physician education programme, CAMP PCI (Coronary artery and myoc...
IC fellows’ training has been affected by pandemic
Trainee interventional cardiologists have raised concerns that reductions in patient numbers und...
Using telemedicine to transform the management of acute myocardial infarction: the Latin America telemedicine infarct network (LATIN) experience
Telemedicine has come into its own during the pandemic. Sameer Mehta details the STEMI treatment...
Blue Sail Medical and Biosensors International acquire TAVI company NVT
Blue Sail Medical has completed the acquisition of Swiss based company NVT AG. The closure of th...
MicroPort obtains CE mark for PathBuilder
MicroPort has been given CE approval for its PathBuilder Steerable Introducer, PathBuilder Trans...
British Heart Foundation calls for urgent resumption of routine services for heart and circulatory diseases
The British Heart Foundation (BHF) is calling on the Government and the NHS to urgently address ...
FDA issues IDE for Impella ECP and EUA for Impella RP
Abiomed has received investigational device exemption (IDE) from the US Food and Drug Administra...
Keith Oldroyd to become CMO at Biosensors
Biosensors International Group has announced the appointment of Keith G Oldroyd to the post of c...
A coordinated strategy provides the best outcomes for aortic arch treatment
Collaboration between cardiothoracic and vascular surgeons is key to achieving success in aortic...
ACC launches summer COVID-19 education series
The American College of Cardiology (ACC) is to host a weekly virtual meeting— the Summer COVID-1...
ESC to stream the latest science in heart failure
The European Society of Cardiology (ESC) has announced that the HFA Discoveries online event will be...
EXCEL: PCI inferior to CABG in Bayesian reanalysis
A Bayesian analysis of EXCEL and other randomised controlled trials comparing coronary artery bypass...
PERSIST-AVR study on Perceval sutureless aortic valve presented at AATS
LivaNova have presented the first data from the Perceval sutureless implant versus standard-aort...
CeloNova completes enrolment in first 14-day DAPT randomised controlled trial
CeloNova BioSciences has announced that it has successfully completed enrolment into the COBRA RED...
Decreased ACE2 levels found in ageing and cardiovascular disease can increase likelihood of severe COVID-19
The reduced levels of angiotensin converting enzyme (ACE) 2 associated with cardiovascular disease a...
PPE guidance for cardiology during COVID-19 pandemic operating in a “vacuum” in UK
Simon Ray, president of the British Cardiovascular Society (BCS), has told the COVID-19 Cardiova...
Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19
A raised troponin level in myocardial injury “greatly alters the prognosis adversely” in COVID-19 pa...
Italy, USA and the UK share their cardiology COVID-19 experiences in LIVE Webinar
The COVID-19 Cardiovascular Conference, hosted as a live webinar by The Imperial College Network...
Daniel M Philbin Jr named new chair of the ACC board of governors
Daniel M Philbin Jr has been named chair of the American College of Cardiology (ACC) board of go...
Live webinar on Thursday 2 April to share COVID-19 cardiovascular experience
The Imperial College Network of Excellence in Vascular Science at Imperial College London (UK) is to...
Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease
The longest follow-up to date of patients with left main coronary artery disease (LMCAD) has fou...
Virtual ACC: Use of radial artery in heart bypass surgery improves patient outcomes
Using the radial artery instead of the saphenous vein for patients undergoing coronary artery by...
Virtual ACC: Combining aspirin with rivaroxaban provides greater absolute risk reduction in diabetes
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative...
Virtual ACC: Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularisation
Treatment with aspirin plus rivaroxaban following lower extremity revascularisation in patients ...
Adapt clinical studies to alleviate effect of pandemic
A viewpoint in the Journal of the American Medical Association (JAMA) has offered potential solu...
Cardiac injury in COVID-19 patients linked with higher death rate
Cardiac injury is common among hospitalised patients with COVID-19, and is associated with a higher ...
CDRH adjusts working practices with medical device companies to deal with COVID-19
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has wr...
BCIS and BCS ratify NHS guidance for cardiology during COVID-19 pandemic
The British Cardiovascular Intervention Society (BCIS) and the British Cardiovascular Society (B...
SCAI launches web section devoted to COVID-19 updates and cancels Scientific Sessions
The Society for Cardiology and Angiography Interventions (SCAI) has set up a dedicated section o...
Duo device for tricuspid repair records first successful use in humans
CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve tec...
One-third of critically ill COVID-19 patients in Washington State series developed cardiomyopathy
A case series of US experience with COVID-19 has upheld suggestions of a link with cardiomyopathy, w...
FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic
The US Food and Drug Administration (FDA) has issued an immediately-in-effect guidance that allo...
First report gives insight on impact of COVID-19 in heart transplant patients
The first report on the impact of COVID-19 on heart transplant recipients has been published in ...
Frailty predicts greater death rate and higher costs after mitral valve surgery
Frailty is an independent predictor of morbidity, death, and increased costs after mitral valve repl...
SCAI issues advice for cath labs in light of COVID-19 pandemic
The Society for Cardiovascular Angiography and Interventions (SCAI) has written an open letter t...
Transcatheter heart valves are overlapping with coronary arteries
Data from a pilot imaging study of commissural alignment in trancatheter aortic valve implantati...
TriGUARD 3 given CE mark for embolic protection during TAVI
European CE mark has been awarded to the TriGUARD 3 cerebral embolic protection (CEP) device fro...
Portola Pharmaceuticals unveils data on Andexxa in patients with multiple types of Factor Xa inhibitor-related bleeds
Portola Pharmaceuticals announced new data that they say reinforces the value of Andexxa (coagulatio...
Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes
Early improvement in health status for patients in the COAPT trial who had transcatheter mitral ...
PCI for chronic total occlusion less successful after bypass surgery
Patients who have a percutaneous coronary intervention (PCI) for chronic total occlusion followi...
Novel device “safely obliterates” left atrial appendage with minimal amount left behind
The novel left atrial appendage (LAA) closure device Appligator (Append Medical) was a finalist ...
Approval of Tendyne TMVI device means physicians now have a portfolio of options for treating mitral regurgitation
Abbott made history in January when it became the first company in the world to receive market a...
ACC.20/WCC will be a virtual meeting
The American College of Cardiology Scientific Session Together with World Congress of Cardiology (AC...
Long-term exercise may lead to aortic enlargement and remodelling
Vascular remodelling may occur in response to sustained, regular exercise, suggests a study of aorti...
Abbott receives CE mark for FlexNav delivery system
Abbott has received CE mark in Europe for the new FlexNav delivery system for the company's Port...
New England Journal of Medicine to review EXCEL data
The New England Journal of Medicine (NEJM) has launched a review into the data from the EXCEL trial,...
Cardiovascular News Issue 56—February 2020: US Edition
NOBLE finds PCI inferior to CABG at five years in left main disease
EXCEL: repeat revasculari...
Cardiovascular News Issue 56—February 2020
NOBLE finds PCI inferior to CABG at five years in left main disease
EXCEL: repeat revasculari...
Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments
Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary artery disease (CAD...
ADVERTORIAL: Further data underline the critical role of Impella Heart Pumps in Protected PCI
Findings from an interim analysis of PROTECT III have added to the evidence for improved outcome...
CryoLife given CE mark for On-X Ascending Aortic Prosthesis
CryoLife has received CE mark for the On-X Ascending Aortic Prosthesis (AAP), allowing resumed d...
FDA issues update on reducing the risk of patient infections during cardiac surgery
The US Food and Drug Administration (FDA) has cleared a new version of the LivaNova Heater-Cooler Sy...
First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system
Endotronix has announced the enrollment of the first two patients in the PROACTIVE-HF trial. The...
Heart Research UK awards grant to University of Leeds to develop new heart failure treatments
A research project at the University of Leeds aiming to identify new drug treatments for heart f...
CRT 2020: TAVI safe at 30 days in low-risk bicuspid aortic stenosis
Transcatheter aortic valve implantation (TAVI) is safe in the short term in low-risk patients wi...
CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality
Patients who develop stage 3 acute kidney injury (AKI) following transcatheter aortic valve impl...
CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial
Biotronik has announced three-year data from the BIOFLOW-V trial, which were presented at the Ca...
Edwards expands its Every Heartbeat Matters initiative
Edwards Lifesciences has announced a new goal for its philanthropic initiative, Every Heartbeat Matt...
Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI
A comparison of newer generation self-expanding valves (SEV) and balloon-expandable valves (BEV)...
Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system
Cardiovalve has received US Food and Drug Administration (FDA) approval for an early feasibility...
“Our goal is to treat more patients with mitral regurgitation”
Last month, Abbott announced US Food and Drug Administration (FDA) approval of a new trial—REPAI...
JIM 2020: Weigh up early and late events in EXCEL to determine treatment for left main disease
Gregg W Stone (Icahn School of Medicine, Mount Sinai, New York, USA) addressed the EXCEL controv...
Nicolas van Mieghem
Nicolas van Mieghem (professor of interventional cardiology, department of cardiology, Thoraxcen...
Orsiro Mission gets CE mark
Biotronik has received CE mark certification for the Orsiro Mission drug-eluting stent (DES) sys...
Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray
Philips has announced a new randomised controlled trial to assess percutaneous coronary interven...
Transcatheter intervention can address “unmet need” in treatment of tricuspid valve disease
Scott Lim (Charlottesville, USA) talks to BLearning Cardio at PCR London Valves 2019 (17–19 Nove...
TAVI enthusiasm should be “tempered” in low-risk patients whilst durability concerns remain
Philippe Pibarot (Québec, Canada) talks to BLearning Cardio at PCR London Valves 2019 (17–19 No...
Germany renews Revivent’s NUB reimbursement status 1 for 2020
BioVentrix has received renewal of the highest priority reimbursement in Germany for its Revivent ...
CABG shows 10-year benefit over PCI in left main patients with high SYNTAX score
Extended 10-year follow-up has demonstrated that in patients with a high SYNTAX score undergoing...
EXCEL may damage relations between interventional cardiologists and cardiac surgeons
The debate over the results of EXCEL shows no sign of abating, and there seems to be a division ...
Portola Pharmaceuticals appoints Rajiv Patni as executive vice president and chief medical officer
Rajiv Patni has been appointed as executive vice president and chief medical officer at Portola ...
Guy’s and St Thomas’ to merge with Royal Brompton & Harefield NHS Foundation Trust
Guy’s and St Thomas’ and Royal Brompton & Harefield NHS Foundation Trusts are to merge. A joint ...
STS 2020: Harness the power of Twitter to give your research greater impact
Highly-tweeted articles are 11 times more likely to be cited than less tweeted articles, Ourania...
STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI
Open heart surgery remains the best option for young and middle-aged adults with aortic valve di...
STS 2020: Enhanced surgical recovery protocols will allow safe three-day discharge
Patients discharged three days after open heart surgery are not at increased risk of complicatio...
Low albumin, anaemia, and slow walking speed predict mortality after TAVI
The largest study to date of the role of frailty indices after transcatheter aortic valve implan...
Further innovation and research is required for thrombus aspiration in PCI
The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing per...
Emboline completes enrolment in SAFEPASS 2 clinical trial
Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emboliner embolic prote...
BioCardia gets FDA clearance for catheter to guide Helix delivery system
BioCardia has received US Food and Drug Administration (FDA) 510(k) clearance for its Morph DNA ...
Spartan Bioscience sets up European advisory board for precision medicine test in cardiac stent patients
Spartan Bioscience, a maker of precision medicine diagnostic solutions, has established a new sc...
EXCEL finds repeat revascularisations following both CABG and PCI lead to increased mortality
A secondary analysis of repeat revascularisation in the EXCEL trial has found that it was associ...
Abbott gets green light for trial on MitraClip in moderate surgical risk patients
Abbott has announced that the US Food and Drug Administration (FDA) has approved a first-of-its-...
Self-expanding valves show good haemodynamic performance in small annuli
A retrospective registry comparing four self-expanding transcatheter heart valves has demonstrat...
FDA approves Abbott heart pump for less invasive surgical approach
Abbott has announced US Food and Drug Administration (FDA) approval of a new alternative surgica...
Jean-Claude Dubacher named chairman and CEO of B Braun Medical
B Braun has announced the appointment of Jean-Claude Dubacher as chairman and CEO. Dubacher join...
Proximo Medical to partner with CeloNova Biosciences
Proximo Medical is to partner with CeloNova Biosciences, supplier of the COBRA PzF nanocoated co...
EXCEL: EACTS reaches out to trial investigators to “resolve concerns”, as CRF commissions independent review
The European Association of Cardio-Thoracic Surgeons (EACTS) has issued a statement reaching out...
EXCEL: EACTS explains its decision-making on left-main guidelines, and AATS calls for all data to be published
The European Association of Cardio-Thoracic Surgeons (EACTS) has published a detailed account of the...
NOBLE finds PCI inferior to CABG at five years in left main disease
Five-year data from the NOBLE trial have confirmed its earlier findings that in patients with un...
EACTS and STS announce strategic partnership
The Society for Thoracic Surgeons (STS) and the European Association of Cardio-Thoracic Surgeons (EA...
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results
George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial sess...
InnovHeart appoints Brent Ratz as independent member of the board
InnovHeart—a developer of novel transcatheter mitral valve replacement (TMVR) systems—has appointed ...
Bioventrix announces positive one-year outcomes for Revivent TC system
Bioventrix has announced online publication of positive one-year results from its CE mark study ...
Further innovation and research is required for thrombus aspiration in PCI
The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing per...
AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease
The largest trial to date to compare revascularisation with a conservative strategy in patients ...
AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury
Preprocedural administration of an oral colchicine load does not reduce the risk of myocardial i...
PCR London Valves 2019: Meril unveils positive data for Myval
Meril has announced positive data on its Myval Transcatheter Heart Valve System at PCR London Va...
Corindus completes first transcontinental simulated telerobotic PCI procedures over 5G, fibre, and public internet networks
Corindus has announced the completion of the first multicity, transcontinental percutaneous coro...
Revivent transcatheter system receives Breakthrough Device Designation from the FDA
The Revivent transcatheter ventricular enhancement system (Bioventrix) has been granted Breakthr...
PCR London Valves 2019: PARTNER 2 analysis shows Sapien 3 valve as durable as surgical valves at four years
An analysis of structural valve deterioration in the PARTNER 2A trial has found that the third g...
PCR London Valves 2019: TRILUMINATE shows safety and efficacy of TriClip maintained at one year
The use of TriClip (Abbott) for edge-to-edge repair in tricuspid regurgitation (TR) remains safe...
PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI
Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is assoc...
PCR London Valves 2019: One-year survival better with Mitra Clip than with medical therapy among COAPT-excluded patients
A single-centre real world experience has found that the vast majority of patients with severe mitra...
More focus needed on best medical therapy and perfusion imaging for CLI procedures
The mortality risk for patients with critical limb ischaemia (CLI) has not changed over the last...
Shockwave commences IVL study to support regulatory approval in Japan
Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) ...
“Cuffless” system to monitor blood pressure could replace traditional methods
A wrist-based optical blood pressure monitor has the potential to replace cuff monitoring system...
Multiphase and early systolic phase CT screening in TMVR superior to end systole analysis at predicting obstruction risk
The use of multiphase computed tomography (CT) assessment, particularly during the early systoli...
GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men
A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no between-sex difference...
Ehtisham Mahmud
The 2019–20 president of the Society for Cardiovascular Angiography and Interventions (SCAI) Eht...
Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients
Patients who have mixed aortic valve disease with pre-existing aortic regurgitation have better ...
US FDA grants Breakthrough Device designation to CorFlow Infusion System
CorFlow Therapeutics has announced that the company has been granted Breakthrough Device designa...
Cardionovum’s coronary DCB receives regulatory approval in China
Cardionovum's Restore paclitaxel-coated balloon for coronary applications has received market ap...
Corindus’ stockholders approve acquisition by Siemens Healthineers
The stockholders of Corindus Vascular Robotics have approved the adoption of the agreement and p...
Two further studies support three-month DAPT following PCI
Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) in patients implante...
Patients with angiographically-intermediate coronary lesions
Using optical coherence tomography (OCT)-to guide percutaneous coronary intervention (PCI) is as...
Diversity strategies in cardiology are not working, study finds
Different strategies are needed to address the continuing lack of diversity in the US cardiology...
Device deaths are under reported, says research letter
A study published as a research letter in JAMA Internal Network has found a “substantial misclas...
Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe
Shockwave Medical, a company which provides intravascular lithotripsy (IVL) to treat complex cal...
International medical graduates in US cardiovascular care are vital to healthcare in the USA and beyond
William W Pinsky and Mandeep R Mehra explain to Cardiovascular News how international medical gr...
Admedus sells CardioCel and VacsuCel to focus on TAVI
Admedus has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 ...
Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels
Penumbra has announced the enrolment of the first patient into the CHEETAH study, a prospective,...
Douglas Drachman named as next vice chair of American College of Cardiology’s Annual Scientific Session
Douglas Drachman has been selected as the next vice chair of the American College of Cardiology’...
Abiomed announces PROTECT III clinical data for protected PCI with Impella
Abiomed has announced the results of PROTECT III, an ongoing, prospective, single-arm US Food an...
AccuCinch ventricular repair system associated with favourable safety profile at 30 days
Data from an interim analysis of heart failure patients treated in the CorCinch FMR study show, ...
TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI
A prespecified analysis of data from the AUGUSTUS study, released at late-breaking session at th...
CE mark granted to the Gore Cardioform ASD Occluder for the treatment of atrial septal defects
The Gore Cardioform Occluder for atrial septal defects (ASD) has received CE mark in Europe, the...
Transseptal puncture techniques must be mastered if physicians wish to perform left-sided interventions
Interest in transseptal puncture has surged with the development of structural interventions for...
Endotronix closes expanded series D financing round of US$70 million for Cordella
Endotronix has announced the expansion of its series D financing round, bringing the total to US...
TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT
ONYX ONE, the first randomised trial to compare a durable polymer drug-eluting stent to a polyme...
TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route
A subanalysis of PARTNER 3 quality of life data demonstrated a modest, but significant, improvem...
TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term
A timing substudy of the COMPLETE trial has found that, compared with culprit-lesion only percut...
TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective
The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in pat...
TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3
The first randomised trial to compare the safety and efficacy of the Acurate neo transcatheter h...
TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems
The Portico IDE study has found that 30-day safety and one-year effectiveness outcomes of a nove...
TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI
Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus aspirin, ticagrelor m...
No device-related mortality at one year for India’s first trancatheter heart valve
Ashok Seth (New Delhi, India) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about ...
Boston Scientific announces schedule of presentations at TCT 2019
Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiov...
Corindus showcasing CorPath GRX system at TCT 2019
Corindus Is to showcase the CorPath GRX system at the Transcatheter Cardiovascular Therapeutics ...
Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation
Abbott has announced its TRILUMINATE pivotal trial to evaluate the safety and effectiveness of t...
ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention
A strategy of complete revascularisation was superior to culprit lesion-only percutaneous corona...
ECHSA 2019: CardioCel acellular bioscaffold handles well
Caner Salih (London, UK) talks to Cardiovascular News about the CardioCel bioscaffold (Admedus) ...
Age alone should not preclude TAVI in patients aged ≥90 years
The clinical frailty score currently used to assess suitability for transcatheter aortic valve i...
Unfilled prescriptions for PCSK9 inhibitors lead to higher rates of cardiovascular events
Patients whose prescription for PCSK9 inhibitors (proprotein convertase subtilisin kexin type 9 ...
The findings on transcatheter aortic valve implantation in patients who are at low risk for cardiac surgery will usher in a new era for patients
Recent low-risk trials for TAVI look set to expand its indications for use. Amar Krishnaswamy an...
Medtronic enters into AI partnership for stroke care
Medtronic has entered into a partnership agreement with Viz.ai to accelerate the adoption of art...
TARGET BP I trial enrols its first patient
The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute i...
Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease
Women who suffer from idiopathic intracranial hypertension (IIH) have twice the risk of heart co...
SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years
Five-year results suggest that surgical aortic valve replacement (SAVR) is associated with lower...
The influence of technology and robotics in the catheterisation laboratory is growing
Thanks to the use of robotics in healthcare, many procedures that were once highly invasive are ...
Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation
Cardiac Dimensions has announced in a press release that its Carillon Mitral Contour S...
Medtronic announces global registry of HVAD thoracotomy implants
Medtronic has announced plans for a global registry of its HeartWare HVAD System, foll...
FEops HEARTguide wins CSI Highlight of the Year Award
FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its FEops HEARTguide unde...
New Liverpool Centre for Cardiovascular Science established
The Liverpool Centre for Cardiovascular Science, an alliance between academia and the NHS, was e...
MeRes100 BRS demonstrates sustained safety and efficacy
Data from the MeRes-1 and MeRes-1 Extend clinical trials, released at EuroPCR 2019 (20–24 May, Paris...
Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold
Admedus has announced positive data from an independent study into the performance of its tissue...
PASCAL poised to rival MitraClip for safety and efficacy
PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraClip (Abbott) for the...
NICE issues recommendations on insertion of cerebral protection devices during TAVI
The National Institute for Health and Care Excellence (NICE) has released evidence-based recommendat...
The evolution of PCR: milestones and achievements in its 30-year journey
2019 saw the 30th anniversary of EuroPCR, with 11,206 participants gathering in Paris. William W...
SCAI document provides advice on cath labs’ financial viability
The Society for Coronary Angiography (SCAI) has issued a statement, endorsed by the Alliance of ...
Cardiologists can help to avert nuclear doomsday
Cardiologists can help to reduce the threat of nuclear war and move “the hands of the Doomsday C...
PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS
Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a...
Early treatment with Helix system improves ejection fraction and symptoms
The Helix biotherapeutic delivery system (Biocardia), which delivers cell therapy to patients wi...
Biotronik announces positive data for Magmaris
A press release from Biotronik highlights data from the BIOSOLVE-IV registry outlining procedura...
FDA approves Cardioform ASD Occluder for the treatment of atrial septal defects
The Cardioform ASD Occluder (Gore Medical) has received US Food and Drug Administration (FDA) pr...
EuroPCR 2019: Ultrasound pulmonary artery denervation “improving patient outcomes”
Alex Rothman (Sheffield, UK) discusses the TROPHY1 study which looked at the safety and efficacy...
American College of Cardiology names its first director of diversity and inclusion
The American College of Cardiology (ACC) has announced the appointment of Ranna Parekh as its firs...
EuroPCR 2019: PARTNER 3 results “disruptive to our practice”
Thomas Modine (Lille, France) talks to Cardiovascular News about the PARTNER 3 trial comparing l...
EuroPCR 2019: VIVALL pilot study shows promise for safe use of Allegra heart valve in bioprostheses
Early experience with the Allegra transcatheter heart valve (New Valve Technology) suggests it is sa...
EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective
Use of a TriClip (Abbott) for edge-to-edge repair in patients with tricuspid regurgitation appears t...
EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR
PCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) issued a s...
EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary syndrome
A consensus paper on the use of intracoronary imaging was released at EuroPCR 2019 (20–24 May, P...
Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR
Using the diastolic pressure ratio (dPR) to identify ischaemia-producing lesions in patients wit...
ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations for its PleuraFlow system
ClearFlow medical device company has announced positive clinical trial results for its PleuraFlo...
USA needs to put greater emphasis on home-based cardiac rehabilitation
A Scientific Statement from the American Association of Cardiovascular and Pulmonary Rehabilitat...
Keith Dawkins appointed as chief medical officer at Shockwave Medical
Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release...
Avance steerable introducer given FDA 510(k) clearance
The AVANCE steerable introducer product family (BioCardia) has received US Food and Drug Adminis...
Cordis expands its interventional cardiology portfolio with full US launch of radial products
Cordis, a Cardinal Health company, has announced the full US launch of its Radial 360 portfolio, off...
FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps
Abiomed has announced an expanded US Food and Drug Administration (FDA) approval for the Impella...
Virtue SEB given breakthrough device designation by FDA
The Virtue (Orchestra BioMed) sirolimus-eluting balloon for the treatment of coronary in-stent r...
Bardy Diagnostics announces $35.5M funding injection
Bardy Diagnostics, provider of ambulatory cardiac monitoring technologies and custom data solutions,...
ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia
One-month dual antiplatelet therapy (DAPT) followed by 12 months of clopidogrel monotherapy leads to...
RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation
Six-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial have found that patients...
Alirocumab receives EC approval in established atherosclerotic cardiovascular disease
The European Commission (EC) has approved the use of alirocumab (Praluent, Sanofi), a PCSK9 inhibito...
Richard Kovacs assumes presidency of the American College of Cardiology
Richard Kovacs has become the new president of the American College of Cardiology (ACC). He official...
2 Heart Research UK funds UCL research to improve baby congenital heart disease diagnosis
National charity, Heart Research UK has granted funding for an innovative research project with ...
AHA 2016: Elizabeth M McNally wins AHA prize for research into genetic flaws responsible for inherited human disorders including heart failure
The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M Mc...
